Condition: Aortic Stenosis Treated With TAVI · Aortic Diseases · Sponsor: EnCompass Technologies, Inc.
The objective of this study is to compare the safety and effectiveness of the F2 Cerebral Protection System (CPS) to a standard of care control group in patients undergoing Transcatheter Aortic Valve Replacement (TF TAVR)
This description comes directly from the study's public registry record.
Kathleen S Calderon · 3072502726 · kcalderon@encompassf2.com
Always discuss trial participation with your own doctor first.
| NCH Baker Hospital-Naples Heart Institute | Naples, Florida, United States | Not Yet Recruiting |
| St. Vincent Hospital | Indianappolis, Indiana, United States | Recruiting |
| Henry Ford Hospital | Detroit, Michigan, United States | Recruiting |
| St. Lukes Hospital Of Kansas City | Kansas City, Missouri, United States | Recruiting |
| Cumc/Nyph | New York, New York, United States | Recruiting |
| Cleveland Clinic Foundation | Cleveland, Ohio, United States | Recruiting |
| Ohio Health Research Institute (aka Riverside Methodist Hospital) | Columbus, Ohio, United States | Not Yet Recruiting |
| University of Virginia Medical Center | Charlottesville, Virginia, United States | Not Yet Recruiting |
| St Andrews War Memorial Hospital | Spring Hill, Queensland, Australia | Not Yet Recruiting |
| Monash Health Public | Clayton, Victoria, Australia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06689839